Takeda Pharmaceutical (TAK) vs United Therapeutics (UTHR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Takeda Pharmaceutical (TAK) has outperformed United Therapeutics (UTHR) over the past year, gaining 29.4% versus a gain of 18.7%. Over five years, UTHR leads with a +184.8% price change compared with +31.3% for TAK. Takeda Pharmaceutical is the larger company by market cap ($59.82 billion vs $23.55 billion), about 2.5 times the size.
On valuation, United Therapeutics trades at a lower forward P/E (16.3x vs 35.3x for Takeda Pharmaceutical). Takeda Pharmaceutical pays a dividend yielding 1068.09%, while United Therapeutics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TAK | UTHR |
|---|---|---|
| Share price | $18.73 | $549.16 |
| Market cap | $59.82B | $23.55B |
| 1-day change | +1.11% | +3.07% |
| YTD return | +18.79% | +9.34% |
| 1-year return | +29.42% | +18.68% |
| 5-year return | +31.35% | +184.80% |
| P/E ratio (TTM) | — | 19.67 |
| Forward P/E | 35.33 | 16.25 |
| EPS (TTM) | $-0.34 | $27.92 |
| Dividend yield | 1068.09% | 0.00% |
| Annual dividend | $200.00 | $0.00 |
| Revenue (latest FY) | — | $3.18B |
| Revenue growth (YoY) | — | +10.61% |
| Net income (latest FY) | — | $1.33B |
| Gross margin | — | 87.92% |
| Operating margin | — | 46.89% |
| Net margin | — | 41.94% |
| 52-week high | $19.10 | $609.35 |
| 52-week low | $12.99 | $409.07 |
| Distance from 52-week high | -1.96% | -9.88% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +17.28% | +18.30% |
| Average volume | 3.04M | 672.80K |
| Shares outstanding | 3.19B | 42.89M |
| Employees | 47,029 | 1,400 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Takeda Pharmaceutical is about 2.5 times larger than United Therapeutics by market value ($59.82B vs $23.55B).
- TAK has outperformed UTHR by 10.7 percentage points over the past year.
- Takeda Pharmaceutical offers a meaningfully higher dividend yield (1068.09% vs 0.00%).
About Takeda Pharmaceutical
TAK stock →Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.
Health Care · Biotechnology: Pharmaceutical Preparations · 47,029 employees
About United Therapeutics
UTHR stock →United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,400 employees
TAK vs UTHR FAQ
Which is bigger, Takeda Pharmaceutical or United Therapeutics?
Takeda Pharmaceutical (TAK) is larger, with a market capitalization of $59.82B compared with $23.55B for United Therapeutics (UTHR).
Which stock has performed better over the past year, TAK or UTHR?
TAK returned +29.42% over the past 12 months, compared with +18.68% for UTHR (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Takeda Pharmaceutical or United Therapeutics?
Takeda Pharmaceutical pays a dividend yielding 1068.09%, while United Therapeutics does not currently pay a regular dividend.
Are Takeda Pharmaceutical and United Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.